. Verve Therapeutics, a wholly owned subsidiary of Eli Lilly & Company, based in Boston, Massachusetts, is a clinical-stage... to novel ‘once and done’ single-course gene editing therapeutics. The company’s advanced development programs – VERVE-102...
and therapeutics across modalities in clinical use;emerging targets with investigational therapeutics in the field;and the unmet... design and engineering;CRISPR and other genome-editing technologies;nonviral gene-delivery methods;in vitro assay...
CRISPR screens, single-cell transcriptomics and lineage tracing, as well as experimental and in silico derived proteomic... genomics screens and other data sets (including RNA-Seq, DRUG-seq, WGS, CRISPR, single cell RNA-Seq, proteomics...
Job Description: Company Overview Since its inception over a decade ago, CRISPRTherapeutics has transformed... and expand its efforts, CRISPRTherapeutics has established strategic partnerships with leading companies including Vertex...
novel target and disease mechanisms and advance therapeutic programs. The team focuses on developing therapeutics.... Develop and implement assays to evaluate potential therapeutics to advance the pre-clinical pipeline. Use of laboratory...
Job Description: Company Overview Since its inception over a decade ago, CRISPRTherapeutics has transformed... and expand its efforts, CRISPRTherapeutics has established strategic partnerships with leading companies including Vertex...
Job Description: Company Overview Since its inception over a decade ago, CRISPRTherapeutics has transformed... and expand its efforts, CRISPRTherapeutics has established strategic partnerships with leading companies including Vertex...
Job Description: Company Overview Since its inception over a decade ago, CRISPRTherapeutics has transformed... and expand its efforts, CRISPRTherapeutics has established strategic partnerships with leading companies including Vertex...
Job Description: Company Overview Founded over a decade ago, CRISPRTherapeutics is a leading biopharmaceutical... and transfusion-dependent beta thalassemia. CRISPRTherapeutics is advancing a broad and diversified pipeline...
a postdoctoral fellow to develop novel approaches to enhance chimeric antigen receptor (CAR-T) cell therapeutics through... with CRISPR/Cas9 gene editing and advanced cell therapy development techniques. Experience with bioinformatics analysis...